Estradiol is in a class of medications called estrogen hormones. It works by replacing estrogen that is normally produced by the body. Most brands of estradiol transdermal patches are used to treat hot flushes (hot flashes; sudden strong feelings of heat and sweating) and/or vaginal dryness, itching, and burning in women who are experiencing menopause (change of life; the end of monthly menstrual periods). Transdermal estradiol is also used to prevent osteoporosis (a condition in which the bones become thin and weak and break easily) in women who are experiencing or have experienced menopause.
The report offers detailed coverage of Estradiol Transdermal System industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Estradiol Transdermal System by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Estradiol Transdermal System market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Estradiol Transdermal System market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Novartis
Allergan
Bayer
Noven Therapeutics
Mylan
Vertical Pharmaceuticals
Perrigo Pharma International
At the same time, we classify Estradiol Transdermal System according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
0.025 mg per day
0.0375 mg per day
0.05 mg per day
0.075 mg per day
0.1 mg per day
Market by Application
Hot flashes
Prevention of postmenopausal osteoporosis
Treatment of hypoestrogenism
Moderate-to-severe vasomotor symptoms
Others
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Estradiol Transdermal System market for the forecast period 2021 - 2025?
• What are the driving forces in the Estradiol Transdermal System market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Estradiol Transdermal System industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?